Anthony Hunt Repligen Corp (RGEN) insider trading activity

Anthony Hunt is of REPLIGEN CORP. Currently has a direct ownership of 109,854 shares of RGEN, which is worth approximately $12.5 Million. The most recent transaction as insider was on May 15, 2025, when has been sold 26,447 shares (Common Stock) at a price of $124.55 per share, resulting in proceeds of $3,293,973. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 110K

19.4% 3M change

33.49% 12M change

Total Value Held $12.5 Million

Anthony Hunt Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 15 2025	SELL Open market or private sale	$3,293,973 $124.55 p/Share	26,447 Reduced 19.4%	109,854 Common Stock
Mar 17 2025	SELL Open market or private sale	$4,048,985 $151.33 p/Share	26,756 Reduced 16.41%	136,301 Common Stock
Mar 17 2025	BUY Exercise of conversion of derivative security	$1,249,505 $46.7 p/Share	26,756 Added 14.1%	163,057 Common Stock
Mar 03 2025	SELL Payment of exercise price or tax liability	$1,575,863 $155.38 p/Share	10,142 Reduced 6.93%	136,301 Common Stock
Feb 27 2025	SELL Payment of exercise price or tax liability	$442,225 $156.54 p/Share	2,825 Reduced 1.89%	146,443 Common Stock
Feb 24 2025	SELL Payment of exercise price or tax liability	$392,081 $164.74 p/Share	2,380 Reduced 1.57%	149,268 Common Stock
Dec 05 2024	BUY Exercise of conversion of derivative security	$399,936 $33.87 p/Share	11,808 Added 7.22%	151,648 Common Stock
Nov 21 2024	SELL Open market or private sale	$3,386,438 $139.67 p/Share	24,246 Reduced 14.78%	139,840 Common Stock
Nov 21 2024	BUY Exercise of conversion of derivative security	$821,212 $33.87 p/Share	24,246 Added 12.87%	164,086 Common Stock
Sep 10 2024	SELL Open market or private sale	$3,224,796 $145.32 p/Share	22,191 Reduced 13.7%	139,840 Common Stock
Sep 10 2024	BUY Exercise of conversion of derivative security	$338,700 $33.87 p/Share	10,000 Added 5.81%	162,031 Common Stock
Sep 03 2024	SELL Sale (or disposition) back to the issuer	-	13,146 Reduced 7.96%	152,031 Common Stock
Jun 14 2024	BUY Open market or private purchase	$248,160 $124.08 p/Share	2,000 Added 1.2%	165,177 Common Stock
May 21 2024	SELL Open market or private sale	$3,385,744 $168.68 p/Share	20,072 Reduced 10.95%	163,177 Common Stock
Mar 18 2024	SELL Bona fide gift	-	2,000 Reduced 1.08%	183,249 Common Stock
Mar 08 2024	SELL Open market or private sale	$3,325,027 $199.02 p/Share	16,707 Reduced 8.27%	185,249 Common Stock
Mar 08 2024	BUY Exercise of conversion of derivative security	$16 $16.55 p/Share	1 Added 0.0%	201,956 Common Stock
Mar 07 2024	SELL Payment of exercise price or tax liability	$561,129 $195.72 p/Share	2,867 Reduced 1.4%	201,955 Common Stock
Mar 05 2024	SELL Payment of exercise price or tax liability	$1,422,408 $195.52 p/Share	7,275 Reduced 3.43%	204,822 Common Stock
Mar 04 2024	SELL Payment of exercise price or tax liability	$215,522 $193.99 p/Share	1,111 Reduced 0.52%	212,097 Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$637,126 $191.79 p/Share	3,322 Reduced 1.53%	213,208 Common Stock
Feb 29 2024	BUY Grant, award, or other acquisition	-	2,504 Added 1.14%	216,530 Common Stock
Feb 27 2024	BUY Grant, award, or other acquisition	-	19,719 Added 8.44%	214,026 Common Stock
Nov 14 2023	SELL Bona fide gift	-	1,000 Reduced 0.51%	194,307 Common Stock
Mar 03 2023	SELL Payment of exercise price or tax liability	$1,549,872 $188.0 p/Share	8,244 Reduced 4.05%	195,307 Common Stock

Also insider at

MASS

908 Devices Inc. Healthcare

BLFS

BIOLIFE SOLUTIONS INC Healthcare

Director

Anthony Hunt

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGEN shares.

Notify only if

Value

Insider Trading

Get notified when an Repligen Corp insider buys or sells RGEN shares.

Notify only if

Operation

Value

Type

News

Receive news related to REPLIGEN CORP

Track Activities on RGEN

Account